Turn Therapeutics (TTRX) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
Turn Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 3 insiders bought $284K and 0 sold $0 of TTRX stock on the open market, including a cluster buy that began Oct 23, 2025.
Get emailed when insiders cluster-buy stocks like TTRX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
TTRX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $308K | 9 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 3 Turn Therapeutics Inc. insiders reported open-market purchases totaling $284K, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Oct 23, 2025, when 3 insiders bought a combined $191K. Among insiders with enough purchase history to measure, Arthur F Golden (Director) has the highest Insider Score at 43.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Dec 12SEC | Zuraiz ChaudharySee Remarks | Buy | 2,50012,500 held (+25%) | $3.50 | $9K | +242.9% | — |
| Nov 25SEC | Arthur F GoldenDirector | Buy | 9,86860,602 held (+19%) | $3.44 | $34K | +248.8% | 43 |
| Nov 24SEC | Arthur F GoldenDirector | Buy | 20,53250,734 held (+68%) | $2.87 | $59K | +318.1% | 43 |
| Nov 21SEC | Zuraiz ChaudharySee Remarks | Buy | 1,4509,000 held (+19%) | $2.61 | $4K | +359.8% | — |
| Nov 21SEC | Zuraiz ChaudharySee Remarks | Buy | 1,00010,000 held (+11%) | $3.29 | $3K | +264.7% | — |
| Nov 17SEC | Zuraiz ChaudharySee Remarks | Buy | 2,5007,550 held (+50%) | $3.62 | $9K | +231.5% | — |
| Oct 29SEC | Abraham ChesedBoard Observer | Buy | 14,2861,447,268 held (+1%) | $4.60 | $66K | +160.9% | — |
| Oct 23SEC | Arthur F GoldenDirector | Buy | 20,20230,202 held (+202%) | $4.95 | $100K | +142.4% | 43 |
| Oct 23SEC | Zuraiz ChaudharySee Remarks | Buy | 5,050new position | $4.95 | $25K | +142.4% | — |
Insiders at Turn Therapeutics Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Arthur F GoldenDirector | $193K | — | Nov 25, 2025 | 43 |
| Abraham ChesedBoard Observer | $66K | — | Oct 29, 2025 | — |
| Zuraiz ChaudharySee Remarks | $50K | — | Dec 12, 2025 | — |
TTRX stock: common questions
Are Turn Therapeutics Inc. insiders buying TTRX stock?
In the past 12 months, 3 insiders reported open-market purchases of TTRX worth $284K. The latest was See Remarks Zuraiz Chaudhary bought $9K of TTRX at $3.50 — raises the stake by 25%.
Are Turn Therapeutics Inc. insiders selling TTRX stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is TTRX's 52-week range?
Over the past year TTRX has traded between $2.71 and $15.34. It last closed at $12.00 on Oct 9, 2026.